Generic Name and Formulations:
Bethanechol chloride 5mg, 10mg, 25mg, 50mg; scored tabs.
Indications for URECHOLINE:
Post-op and post-partum nonobstructive urinary retention and retentive neurogenic urinary atony.
Take on empty stomach. Initially 5–10mg every hour until effective or max 50mg, then 10–50mg 3–4 times daily.
Hyperthyroidism. Peptic ulcer. Asthma. Bradycardia. Hypotension. Vasomotor instability. Coronary artery disease. Epilepsy. Parkinsonism. Obstructive uropathies. Questionable GI or bladder integrity. Obstructive, spastic, inflammatory GI disorders. Vagotonia. Peritonitis. When increased GI or bladder muscle activity may be harmful.
Reflux urinary infection. Pregnancy (Cat.C). Nursing mothers: not recommended.
Severe abdominal symptoms and hypotension with ganglionic blockers.
Cholinergic effects, GI upset, asthma, headache, facial flushing, malaise, orthostatic hypotension.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies